Tredje AP fonden Reduces Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Tredje AP fonden lessened its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 50.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,439 shares of the medical device company's stock after selling 15,438 shares during the period. Tredje AP fonden's holdings in Cooper Companies were worth $1,419,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Ashton Thomas Securities LLC purchased a new stake in Cooper Companies during the 3rd quarter valued at about $25,000. Covestor Ltd grew its stake in Cooper Companies by 144.9% during the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company's stock valued at $37,000 after acquiring an additional 200 shares in the last quarter. Byrne Asset Management LLC purchased a new stake in Cooper Companies during the 4th quarter valued at about $33,000. OFI Invest Asset Management purchased a new stake in Cooper Companies during the 4th quarter valued at about $34,000. Finally, Brown Brothers Harriman & Co. grew its stake in Cooper Companies by 191.0% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company's stock valued at $46,000 after acquiring an additional 275 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on COO. Piper Sandler reissued an "overweight" rating and issued a $115.00 price target (down previously from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. Citigroup dropped their price target on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a research note on Friday, March 7th. Robert W. Baird dropped their price target on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a research note on Friday, March 7th. Stifel Nicolaus dropped their price target on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a research note on Friday, March 7th. Finally, JPMorgan Chase & Co. dropped their price target on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a research note on Friday, March 7th. Four analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, Cooper Companies presently has an average rating of "Moderate Buy" and a consensus price target of $111.89.

Remove Ads

Cooper Companies Stock Up 0.1 %

Shares of COO traded up $0.08 during midday trading on Wednesday, reaching $80.12. The stock had a trading volume of 2,779,841 shares, compared to its average volume of 1,271,113. The Cooper Companies, Inc. has a 1-year low of $77.05 and a 1-year high of $112.38. The company's fifty day simple moving average is $90.68 and its two-hundred day simple moving average is $98.56. The company has a market cap of $16.02 billion, a price-to-earnings ratio of 41.09, a PEG ratio of 2.25 and a beta of 1.02. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting analysts' consensus estimates of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. Equities research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.